Kenerenone key intermediate and preparation method thereof
Through nucleophilic substitution and photooxidation reaction, the synthesis of key intermediates of nonelectrone is simplified, and the existing process costs and pollution are solved, and efficient and environmentally friendly industrial production is achieved.
Patent Information
- Application Number
- CN202411474994.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-22
- Publication Date
- 2024-12-06
AI Technical Summary
The existing synthesis process of key nonelectronone intermediates has high cost, high pollution and difficulty in industrialization, mainly due to the use of precious catalysts and highly toxic substances, and the complex process is not suitable for commercial production.
Using 3-halo-4-methylbenzonitrile as raw material, through nucleophilic substitution and photooxidation reaction, Ulmann coupling and photooxidation technology, simplifies it into a two-step chemical reaction, avoiding the use of expensive palladium catalysts and dangerous reagents. Suitable for industrial production.
It achieves high purity, high yield, mild and controllable reaction conditions, simple operation, suitable for industrial production, and reduces production costs and environmental pollution.
Smart Images

Figure BDA0005095831570000011 
Figure BDA0005095831570000021 
Figure BDA0005095831570000022
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of pharmaceutical synthesis, and in particular to a key intermediate of finerenone and a preparation method thereof. Background Art
[0002] Finerenone is the first non-steroidal selective mineralocorticoid receptor antagonist with confirmed renal and cardiovascular benefits in patients with chronic kidney disease and type 2 diabetes. On July 9, 2021, Bayer announced that the U.S. Food and Drug Administration (FDA) approved the first non-steroidal selective mineralocorticoid receptor antagonist, finerenone, for marketing in the United States. Finerenone 10 mg or 20 mg can be used to reduce the risk of sustained decline in eGFR, end-stage renal disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adult patients with chronic kidney disease and type 2 diabetes. 4-Cyano-2-methoxybenzaldehyde is a key intermediate in the synthesis of finerenone. The synthesis process reported in the existing literature has problems such as large impurities, low yield, and high cost. It is necessary to develop a production process with high product quality and easy industrialization.
[0003] At present, the synthesis of 4-cyano-2-methoxybenzaldehyde mainly includes the following routes:
[0004] Route 1 already exists in the market: 3-methoxy-4-iodo-bromobenzene is used as the starting material, and then the product is hydroformylated by Bouveault reaction and finally cyanided to obtain the key intermediate of phenaretin. This method requires expensive 3-methoxy-4-iodo-bromobenzene as the raw material, hydroformylation in an ultra-low temperature environment, the use of dangerous butyl lithium reagents and high energy consumption; cyanidation uses precious metal palladium as a catalyst, which is difficult to recycle and reuse, has high costs and is difficult to control the reaction, and is not suitable for industrialization.
[0005]
[0006] Route 2: 4-bromo-2-hydroxybenzoic acid is used as the raw material, and then reduced to aldehyde after dimethylation, and finally cyanided to obtain the key intermediate of phenarenic acid. This route uses highly toxic dimethyl sulfate as a methylation reagent, and also uses expensive palladium reagents, which is costly. In addition, red aluminum post-treatment uses a large amount of acid water, which is very unfriendly to the environment. The cost of three waste treatments is too high, and it is not suitable for commercialization.
[0007]
[0008] Route 3: 3-methoxy-4-methylbenzonitrile is condensed with DMF-DMA and then oxidized to obtain the target product. Although the route is short, high-energy sodium periodate is used as an oxidant. The oxidation process is a dangerous process in production, and its industrialization is greatly restricted.
[0009]
[0010] Route 4: 4-methyl-3-methoxybenzoic acid is amidated, dehydrated to form a nitrile, brominated under the catalysis of a photo-radical initiator, and alkaline hydrolyzed to form an aldehyde. The steps are long and require a large amount of ammonia water and thionyl chloride, which will cause highly polluted wastewater. In addition, it is difficult to obtain a dibrominated product with good selectivity by bromination, and the monobrominated product affects the atomic utilization rate.
[0011]
[0012] In summary, although there are many market routes, they either use expensive catalyst Pd, or use highly toxic substances, or are dangerous processes, resulting in high costs, high pollution, and difficulty in industrial production. Summary of the invention
[0013] Based on the technical problems existing in the background technology, the present invention proposes a key intermediate of finerenone and a preparation method thereof. The present invention uses cheap and easily available 3-halogen-4-methylbenzonitrile (obtained by halogenation of p-methylbenzonitrile), obtains 3-methoxy-4-methylbenzonitrile by an Ullmann coupling method with a good conversion rate, and then directly obtains the target product by a one-step free radical photo-oxidation. The steps are short, the raw and auxiliary materials used are cheap and easy to obtain, and the method is suitable for industrialization, and has great market prospects.
[0014] The present invention provides a method for preparing a key intermediate of finerenone, which uses 3-bromo-4-methylbenzonitrile as a raw material, and sequentially undergoes nucleophilic substitution and oxidation reactions to obtain the key intermediate of finerenone. The synthetic route is as follows:
[0015]
[0016] X is selected from one of F, Cl, Br and I; and R is methyl.
[0017] The present invention provides a method for preparing a key intermediate of finerenone, comprising the following steps:
[0018] S1, mixing the compound of formula 1, a base, a metal salt, an alcohol, and an amide compound uniformly, adding the mixture to solvent A, reflux reaction, quenching, diluting extraction, drying and concentrating, crystallizing, filtering and drying to obtain a compound of formula 2;
[0019] S2. Dissolve the compound of formula 2 and the catalyst in solvent B, add an oxidant, and react under light conditions. After the reaction is completed, add alkaline water, and then add an extractant to extract, dry and concentrate, crystallize, filter and dry to obtain the compound of formula 3, which is the key intermediate of finerenone.
[0020] Preferably, in S1, the molar ratio of the compound of formula 1 to the alkali, metal salt, alcohol, and amide compound is 1:(1-3):(1-3):(0.01-0.1):(0.01-0.1), and more preferably 1:(1.2-1.5):(2-2.5):(0.03-0.07):(0.03-0.07).
[0021] Preferably, in S1, the base is selected from one or more of sodium carbonate, potassium carbonate, potassium phosphate, sodium phosphate, sodium hydroxide, sodium hydride, and alkali metal salts of alcohols; wherein the alkali metal salt of alcohol is selected from one or more of sodium methoxide and potassium methoxide, more preferably potassium methoxide.
[0022] Preferably, in S1, the metal salt is selected from one or more of cupric chloride, cuprous chloride, cupric bromide, cuprous bromide, cupric iodide, cuprous iodide, nickel chloride, nickel bromide, and nickel iodide, more preferably cupric chloride.
[0023] Preferably, in S1, the amide compound is selected from one or more of aromatic acid amide, sulfonamide, oxalic acid amide, N,N-dimethyl oxalyl diamide, N,N-diethyl oxalyl diamide, N,N-dimethoxyethyl oxalyl diamide, N,N-dimethoxypropyl oxalyl diamide, oxalyl diamide, N,N-dinaphthyl oxalyl diamide, N,N-dibenzyl oxalyl diamide, and N,N-diphenylethyl oxalyl diamide, more preferably oxalyl diamide.
[0024] Preferably, in S1, solvent A is selected from one or more of 1,4-dioxane, DMSO, acetonitrile, and DMF, more preferably DMSO.
[0025] Preferably, in said S1, the reaction temperature is 70-120°C, more preferably 80-90°C.
[0026] Preferably, in S1, the quenching acid used for quenching is selected from one or more of hydrochloric acid, acetic acid and sulfuric acid, more preferably hydrochloric acid.
[0027] Preferably, in S1, the extraction solvent used for extraction is selected from one or more of ethyl acetate, dichloromethane, chloroform and toluene, more preferably ethyl acetate.
[0028] Preferably, in S1, the crystallization solvent used for crystallization is selected from one or more of methanol, ethanol, ethyl acetate and acetone, more preferably methanol.
[0029] Preferably, in said S1, the crystallization temperature is -10 to 10°C, preferably 0 to 5°C.
[0030] Preferably, in S2, solvent B is selected from one or more of carbon tetrachloride, chloroform, benzene and acetonitrile, more preferably carbon tetrachloride.
[0031] Preferably, in S2, the catalyst is selected from one or more of TEMPO, AIBN, BPO, carbon tetrabromide, and 2,3,5,6-tetrafluoro-p-dibenzonitrile, more preferably carbon tetrabromide.
[0032] Preferably, in S2, the oxidant is selected from one or more of acidic potassium permanganate, manganese dioxide, air, and oxygen, more preferably oxygen.
[0033] Preferably, in S2, the alkaline water is selected from one or more of 0.5M sodium hydroxide aqueous solution, saturated sodium carbonate aqueous solution, and saturated sodium bicarbonate aqueous solution, more preferably saturated sodium bicarbonate solution.
[0034] Preferably, in S2, the extractant is selected from one or more of dichloromethane, ethyl acetate and chloroform, more preferably ethyl acetate.
[0035] Preferably, in S2, the crystallization solvent used for crystallization is selected from one or more of methanol, ethanol and acetone, preferably methanol.
[0036] Preferably, in S2, the illumination includes high pressure mercury lamp, LED, CFL or sunlight, more preferably LED.
[0037] Preferably, in S2, the wavelength of the light is 380nm-740nm, the light power is 10-18W, more preferably 400-450nm, and the power is 14-16W.
[0038] Preferably, in S2, the molar ratio of the compound of formula 2 to the catalyst is 1:(0.01-0.50), more preferably 1:(0.1-0.2).
[0039] The present invention also provides a key intermediate of finerenone prepared by the preparation method.
[0040] The beneficial effects of the present invention are:
[0041] The preparation method provided by the present invention is to use 3-halogen-4-methylbenzonitrile as a raw material, obtain a compound of formula 2 after nucleophilic substitution; the compound of formula 2 is oxidized to obtain a compound of formula 3, i.e., a key intermediate of finerenone. The present invention can obtain the final product, the key intermediate of finerenone, through only two chemical reactions. Compared with the prior art, the synthesis route of the present invention is novel, and Ullmann coupling and photooxidation are introduced into the synthesis application of the key intermediate of finerenone for the first time. The reaction steps are few, and the raw materials and reagents used in the reaction are cheap and easy to obtain, and there is no need to use expensive palladium catalysts and dangerous reagents. It is green and environmentally friendly, the reaction conditions are mild and controllable, the operation is simple, the product purity is high, the yield is high, and it is suitable for industrial production. The present invention has broad prospects and industrial application value. DETAILED DESCRIPTION
[0042] The technical solution of the present invention is described in detail through specific embodiments.
[0043] Unless otherwise specified, the materials, reagents, etc. used in the following examples and comparative examples can be obtained from commercial sources.
[0044] Example 1
[0045] A method for preparing a key intermediate of finerenone comprises the following steps:
[0046] S1. Synthesis of compound of formula 2
[0047]
[0048] At room temperature and under nitrogen protection, the compound of formula 1 (19.6 g, 0.1 mol), copper chloride (20 g, 0.2 mol), potassium methoxide (8.42 g, 0.12 mol), methanol (0.1 g, 0.003 mol), and oxalyl diamide (0.26 g, 0.003 mol) were added to 100 mL DMSO, and the temperature was raised to 90°C for reaction for 18 h. After the reflux reaction was completed, the mixture was quenched with hydrochloric acid, 200 mL of water was added, and the mixture was extracted with 200 mL*3 ethyl acetate, dried and concentrated to dryness, 50 mL of methanol was added, and the mixture was crystallized at 0°C for 8 h, filtered and dried to obtain 13.8 g of the compound of formula 2 with a purity of 99.4% and a yield of 94%.
[0049] S2. Synthesis of compounds of formula 3
[0050]
[0051] At room temperature and under nitrogen protection, the compound of formula 2 (14.7 g, 0.1 mol) and carbon tetrabromide (3.32 g, 0.01 mol) were dissolved in 150 mL of carbon tetrachloride. After oxygen replacement, oxygen was continuously introduced and the mixture was irradiated under a 400 nm 14 w LED lamp for 2 h. After the reaction was completed, 100 mL of saturated sodium bicarbonate aqueous solution was added, and 200 mL*3 ethyl acetate was added for extraction. The mixture was dried and concentrated to dryness, 30 mL of methanol was added, and the temperature was lowered to 0°C for crystallization. The mixture was filtered and dried to obtain 15.8 g of the compound of formula 3 with a purity of 99.3% and a yield of 98%.
[0052] Example 2
[0053] A method for preparing a key intermediate of finerenone comprises the following steps:
[0054] S1. Synthesis of compound of formula 2
[0055]
[0056] At room temperature and under nitrogen protection, the compound of formula 1 (15.4 g, 0.1 mol), copper bromide (55.84 g, 0.25 mol), potassium carbonate (20.72 g, 0.15 mol), methanol (0.22 g, 0.007 mol), N,N-dimethyloxalyl diamide (0.82 g, 0.007 mol) were added to 300 mL of dioxane, and the temperature was raised to 85°C for reaction for 26 h. After the reaction was completed, acetic acid was used for quenching, 150 mL of water was added, and 200 mL*3 of dichloromethane was used for extraction, and the mixture was dried and concentrated to dryness. 30 mL of acetone was added, and the mixture was crystallized at -5°C for 12 h, filtered and dried to obtain 12.95 g of the compound of formula 2 with a purity of 99.1% and a yield of 88%.
[0057] S2. Synthesis of compounds of formula 3
[0058]
[0059] At room temperature, the compound of formula 2 (14.714 g, 0.1 mol) and TEMPO (3.316 g, 0.02 mol) were dissolved in 200 mL of acetonitrile, placed under 450 nm 16w CFL lamp for irradiation, and allowed to react for 6 hours. After the reaction, 100 mL*2 saturated aqueous sodium carbonate solution was added, and 200 mL*3 dichloromethane was added for extraction. The mixture was dried and concentrated to dryness, and 40 mL of acetone was added. The mixture was cooled to -5°C for crystallization, and filtered and dried to obtain 15.41 g of the compound of formula 3 with a purity of 99.5% and a yield of 95.6%.
[0060] Example 3
[0061] A method for preparing a key intermediate of finerenone comprises the following steps:
[0062] S1. Synthesis of compound of formula 2
[0063]
[0064] At room temperature and under nitrogen protection, the compound of formula 1 (24.3 g, 0.1 mol), nickel chloride (29.81 g, 0.23 mol), sodium phosphate (8.42 g, 0.14 mol), methanol (0.1 g, 0.005 mol), N,N-dimethoxyethyl oxalyl diamide (1.02 g, 0.005 mol) were added to 250 mL DMSO, and the temperature was raised to 120°C for reaction for 24 h. After the reaction was completed, the reaction was quenched with a hydrochloric acid solution, 300 mL of water was added, and the mixture was extracted with 300 mL*3 chloroform, dried and concentrated to dryness, 75 mL of ethanol was added, and the mixture was crystallized at 0°C for 8 h, filtered and dried to obtain 13.25 g of the compound of formula 2 with a purity of 99.4% and a yield of 90%.
[0065] S2. Synthesis of compounds of formula 3
[0066]
[0067] At room temperature and under nitrogen protection, the compound of formula 2 (14.7 g, 0.1 mol) and AIBN (3.28 g, 0.02 mol) were dissolved in 250 mL of chloroform, potassium permanganate (7.9 g, 0.05 mol) was slowly added, and the mixture was exposed to sunlight for 10 h. After the reaction, 50 mL of 0.5 M sodium hydroxide aqueous solution was added, and 200 mL*3 of chloroform was added for extraction. The mixture was dried and concentrated to dryness, 60 mL of ethanol was added, and the temperature was lowered to 0°C for crystallization. The mixture was filtered and dried to obtain 15.47 g of the compound of formula 3 with a purity of 99.5% and a yield of 96%.
[0068] Example 4
[0069] A method for preparing a key intermediate of finerenone comprises the following steps:
[0070] S1. Synthesis of compound of formula 2
[0071]
[0072] At room temperature and under nitrogen protection, the compound of formula 1 (13.5 g, 0.1 mol), copper iodide (57.4 g, 0.3 mol), sodium hydroxide (12 g, 0.3 mol), methanol (0.32 g, 0.01 mol) and N,N-dibenzyloxalyl diamide (2,681 g, 0.01 mol) were added to 200 mL of acetonitrile, and the temperature was raised to 75°C for reaction for 24 h. After the reaction was completed, hydrochloric acid was used to quench, 300 mL of water was added, and the mixture was extracted with 200 mL*3 ethyl acetate, dried and concentrated to dryness, 50 mL of ethanol was added, and the mixture was crystallized at 0°C for 48 h. The mixture was filtered and dried to obtain 12.1 g of the compound of formula 2 with a purity of 98.5% and a yield of 82%.
[0073] S2. Synthesis of compounds of formula 3
[0074]
[0075] At room temperature and under nitrogen protection, the compound of formula 2 (14.7 g, 0.1 mol) and BPO (3.63 g, 0.015 mol) were dissolved in 200 mL of benzene, and manganese dioxide (2.61 g, 0.03 mol) was slowly added, and the mixture was irradiated under a 430 nm 15 W high pressure mercury lamp for 1 h. After the reaction was completed, 100 mL of saturated sodium bicarbonate aqueous solution was added, and 200 mL*3 of chloroform was added for extraction, and the mixture was dried and concentrated to dryness. 30 mL of methanol was added, and the temperature was lowered to 0°C for crystallization. The mixture was filtered and dried to obtain 15.6 g of the compound of formula 3 with a purity of 99.3% and a yield of 96.8%.
[0076] Embodiment 5 to Embodiment 11
[0077] The only difference between Examples 5 to 11 and Example 1 is that the illumination wavelength and illumination power are different in the synthesis of S2 and Formula 3 compounds, as shown in Table 1. The purity, output and yield of the obtained Formula 3 compounds are shown in Table 1.
[0078] Table 1
[0079]
[0080]
[0081] Example 12 to Example 20
[0082] The only difference between Examples 12 to 20 and Example 1 is that the type and content of the amide compound in the synthesis of the compound of Formula 2 in S1 are different (see Table 2 for details), and the yield and purity, output and yield of the compound of Formula 2 and the compound of Formula 3 are shown in Table 2.
[0083] Comparative Example 1 to Comparative Example 2
[0084] The difference between Comparative Examples 1 to 2 and Example 1 is that the type and content of the amide compound in the synthesis of the compound of Formula 2 in S1 are different (see Table 2 for details). The yield and yield of the compound of Formula 2 are shown in Table 2.
[0085] Table 2
[0086]
[0087]
[0088] From the above results, it can be seen that the synthesis route of the present invention is novel, and Ullmann coupling and photooxidation are introduced into the synthesis application of the key intermediate of finerenone for the first time, the reaction steps are few, the raw materials and reagents used in the reaction are cheap and easy to obtain, and there is no need to use expensive palladium catalysts and dangerous reagents. It is green and environmentally friendly, the reaction conditions are mild and controllable, the operation is simple, the product purity is high, the yield is high, and it is suitable for industrial production. It can be seen from Comparative Example 1, Comparative Example 2 and Example 1 that when the content of oxalyl diamide is low or no oxalyl diamide is added, the yield of the compound of formula 2 is significantly reduced, which will directly affect the yield of the key intermediate of finerenone.
[0089] In summary, the preparation method of the key intermediate of finerenone provided by the present invention is simple to operate, green and environmentally friendly, has high product purity and high yield, and is suitable for industrial production.
[0090] The above description is only a preferred specific implementation manner of the present invention, but the protection scope of the present invention is not limited thereto. Any technician familiar with the technical field can make equivalent replacements or changes according to the technical scheme and inventive concept of the present invention within the technical scope disclosed by the present invention, which should be covered by the protection scope of the present invention.
Claims
1. A method for preparing a key intermediate of finerenone, It is characterized in that Using 3-halogen-4-methylbenzonitrile as raw material, the key intermediate of finerenone is obtained by nucleophilic substitution and oxidation reaction in sequence; the synthetic route is as follows: X is selected from one of F, Cl, Br, and I; R is methyl; The preparation method comprises the following steps: S1, mixing the compound of formula 1, a base, a metal salt, an alcohol, and an amide compound uniformly, adding the mixture to solvent A, reflux reaction, quenching, diluting extraction, drying and concentrating, crystallizing, filtering and drying to obtain a compound of formula 2; S2. Dissolve the compound of formula 2 and the catalyst in solvent B, add an oxidant, and react under light conditions. After the reaction is completed, add alkaline water, and then add an extractant to extract, dry and concentrate, crystallize, filter and dry to obtain the compound of formula 3, which is the key intermediate of finerenone.
2. The preparation method according to claim 1, It is characterized in that In the S2, the wavelength of the light is 380nm-740nm, and the light power is 10-18W.
3. The preparation method according to claim 1, It is characterized in that In the S1, the molar ratio of the compound of formula 1 to the alkali, metal salt, alcohol, and amide compound is 1:(1-3):(1-3):(0.01-0.1):(0.01-0.1).
4. The preparation method according to claim 1, It is characterized in that In the S1, the base is selected from one or more of sodium carbonate, potassium carbonate, potassium phosphate, sodium phosphate, sodium hydroxide, sodium hydride, and alkali metal salts of alcohols; the metal salt is selected from one or more of cupric chloride, cuprous chloride, cupric bromide, cuprous bromide, cupric iodide, cuprous iodide, nickel chloride, nickel bromide, and nickel iodide; the amide compound is selected from one or more of aromatic acid amide, sulfonamide, oxalic acid amide, N,N-dimethyl oxalyl diamide, N,N-diethyl oxalyl diamide, N,N-dimethoxyethyl oxalyl diamide, N,N-di One or more of methoxypropyl oxalamide, oxalamide, N,N-dinaphthyl oxalamide, N,N-dibenzyl oxalamide, and N,N-diphenylethyl oxalamide; solvent A is selected from one or more of 1,4-dioxane, DMSO, acetonitrile, and DMF; the quenching acid is selected from one or more of hydrochloric acid, acetic acid, and sulfuric acid; the extraction solvent is selected from one of ethyl acetate, dichloromethane, chloroform, and toluene; the crystallization solvent is selected from one or more of methanol, ethanol, ethyl acetate, and acetone.
5. The preparation method according to claim 1, It is characterized in that In the S2, the catalyst is selected from one or more of TEMPO, AIBN, BPO, carbon tetrabromide, and 2,3,5,6-tetrafluoro-p-dibenzonitrile.
6. The preparation method according to claim 1, It is characterized in that In the S2, the molar ratio of the compound of formula 2 to the catalyst is 1:(0.01-0.50).
7. A key intermediate of finerenone, It is characterized in that It is prepared by the preparation method according to any one of claims 1 to 6, and its structural formula is as follows:
